OKT3 resistant rejection in liver transplant patients.
Sutherland
F
F
Department of Surgery and Medicine, University and Children's Hospital, University of Western Ontario, London, Canada.
Lazarovits
A
A
Aboujaoude
M
M
Grant
D
D
Ghent
C
C
Sommerauer
J
J
Wall
W
W
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D017252:CD3 Complex; D002648:Child; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology*; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell